Thursday, October 11, 2007

Join us for a one-day conference that will examine the latest issues at the intersection of IP, business and finance. Topics will include:

• How to manage patent infringement litigation
• Is an IPO right for your company?
• Open source update and IP filing strategies for software companies
• Business strategies in view of the new patent rules
• Mock IP due diligence
• Supreme Court's renewed interest in IP
• Patent law changes continue

 

Hyatt Regency San Francisco
5 Embarcadero Center
San Francisco, California 94111
(415) 788-1234
www.sanfranciscoregency.hyatt.com

• 6.0 hours of MCLE Credit will be available for attorneys.

---

LIST OF SPEAKERS

Allen Anderson, Executive Vice President, Synergy & Innovation
Experian Information Systems

Jeremiah Chan, Intellectual Property Counsel
JDS Uniphase

Jackie Collins, Vice President & General Counsel
Nobel Biocare USA

Rebecca Holbrook, General Counsel
Fisher & Paykel Appliances

Sujal Patel, Chairman & CTO
Isilon Systems

Brian Rowbotham, Managing Partner
Rowbotham & Company

Ido Sarig, Venture Partner
Thomas Weisel Venture Partners

Scott Wolf, Venture Partner
Prospect Ventures

Knobbe Martens Representatives:
Don Martens, Of Counsel
Adeel Akhtar, Partner
William Bunker, Partner
Andrew Merickel, Partner
Gerard von Hoffmann, Partner
Joseph Re, Partner



CONFERENCE HIGHLIGHTS


How to Manage Patent Infringement Litigation
A panel of in-house counsel and trial attorneys will discuss lessons learned from managing and conducting complex patent infringement litigation. The panel will provide commentary based on past successes, as well as identifying potential pitfalls and solutions for avoiding/addressing these issues. You will not was to miss their insights and war stories!

Is an IPO Right for Your Company?
Hear a panel of corporate executives and investment professionals discuss their experiences as well as current trends in the warming IPO climate. Panel members will share the details and lessons learned from recent IPO experiences. The panel will also discuss rising activity and liquidity trends and the reopening of the public markets.

Open Source Update and IP Filing Strategies for Software Companies
This session will focus on strategies for software-implemented inventions both in the U.S. and abroad. We will discuss developments in foreign strategies as well as an update on the open source issue.

Business Strategies in View of the New Patent Rules
Learn about the impact of new United States Patent Office rule changes and recent Federal Circuit decisions on technology companies. Experts will offer their insights into the IP issues that may result from the rule changes and how they plan to modify their patent strategies. In addition, the speakers will share their perspectives regarding the duty of disclosure and inequitable conduct in view of the Federal Circuit's recent McKesson decision.

Mock IP Due Diligence
This session will explore IP issues facing investors, acquirers and companies during due diligence. Panelists role-playing both sides of a potential investment, including investor and company representatives and IP counsel, will walk through common due diligence issues and problems using the example of a hypothetical medical device company seeking financing and positioning itself for acquisition.

Supreme Court's Renewed Interest in IP
In 2006 and 2007, the U.S. Supreme Court chose to review a number of high profile patent-related cases addressing a variety of issues, including patent licenses, declaratory judgment jurisdiction, damages and obviousness. Intellectual property specialists expected the cases to have a dramatic impact on patent practice, and the decisions lived up to the hype. Panelists will discuss how decisions in MedImmune, KSR, Microsoft and other cases have affected intellectual property prosecution, enforcement and licensing, and what companies should be doing in response to these decisions.

Lunch Keynote - Patent Law Changes Continue
Join us for an update on the latest developments in U.S. patent law, including proposed patent legislation before the U.S. Congress.